COEXISTENCE OF CELIAC DISEASE AND SYSTEMIC LUPUS ERYTHEMATOSUS IN A 6-YEAR-OLD GIRL-CASE REPORT

Authors

  • Geanina Irina CRISCOV University of Medicine and Pharmacy “Grigore T. Popa”- Iaşi
  • A.B. STANA University of Medicine and Pharmacy “Grigore T. Popa”- Iaşi
  • Ileana Katerina IONIUC University of Medicine and Pharmacy “Grigore T. Popa”- Iaşi
  • Mihaela Monica ALEXOAE University of Medicine and Pharmacy “Grigore T. Popa”- Iaşi
  • Evelina MORARU University of Medicine and Pharmacy “Grigore T. Popa”- Iaşi

Abstract

Systemic lupus erythematosus (SLE) is a serious and potentially fatal syndrome characterized by an autoimmune assault on various organs and systems that may include the skin, joints, central nervous system, heart and kidneys. Recent research shows that gluten sensitivity causes more than just celiac disease and gluten has been linked to numerous autoimmune conditions. We report here a 6-year-old girl presenting with malaise, abdominal pain, loss of appetite, abdominal distension. After three weeks she developed other symptoms such as arthralgias, malar rash, being finally diagnosed with SLE and possible autoimmune hepatitis. The suspicion of celiac disease was based on a combination of symptoms (poor growth, iron deficiency anemia, chronic abdominal pain, abdominal distension, constipation, “sad child”), IgA deficiency, in the presence of SLE diagnosis. Positive diagnosis of celiac disease was confirmed by the presence of an anti IgG anti-transglutaminase antibodies titer of 120 EU/ml (normally less than 20 EU/ml). Small bowel biopsy showed a IIIB1 stage according to the Marsh classification. Three methylprednisolone pulses were promptly administered, followed by oral prednisone (2 mg/kgbw/day) with a good outcome.

Author Biographies

  • Geanina Irina CRISCOV, University of Medicine and Pharmacy “Grigore T. Popa”- Iaşi

    Faculty of Medicine
    Department of Mother and Child Medicine

  • A.B. STANA, University of Medicine and Pharmacy “Grigore T. Popa”- Iaşi

    Faculty of Medicine
    Department of Mother and Child Medicine

  • Ileana Katerina IONIUC, University of Medicine and Pharmacy “Grigore T. Popa”- Iaşi

    Faculty of Medicine
    Department of Mother and Child Medicine

  • Mihaela Monica ALEXOAE, University of Medicine and Pharmacy “Grigore T. Popa”- Iaşi

    Faculty of Medicine
    Department of Mother and Child Medicine

  • Evelina MORARU, University of Medicine and Pharmacy “Grigore T. Popa”- Iaşi

    Faculty of Medicine
    Department of Mother and Child Medicine

References

1. Hu W, Ren H. A meta-analysis of the association of IRF5 polymorphism with systemic lupus erythe-matosus. Int J Immunogenet. 2011; 38(5): 411-417.
2. Petty RE, Laxer RM. Systemic lupus erythematosus. In: Cassidy JT, Petty RE, Laxer RM, et al. eds. Textbook of Pediatric Rheumatology, 5th Ed. Philadelphia: Elsevier Saunders, 2005, 342–391.
3. Tucker LB, Menon S, Schaller JG, et al. Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol 1995; 34: 866–872.
4. Rensch MJ, Szyjkowski R, Shaffer RT, et al. The prevalence of celiac disease autoantibodies in patients with systemic lupus erythematosus. Am J Gastroenterol. 2001; 96: 1113–1115.
5. Gupta D, Mirza N. Systemic lupus erythematosus, celiac disease and antiphospholipid antibody syn-drome: a rare association. Rheumatol Int. 2008; 28: 1179–1180.
6. Hrycek A, Siekiera U. Coeliac disease in systemic lupus erythematosus: a case report. Rheumatol Int. 2008; 28: 491–493.
7. Jump up Iaccarino (Jun 2012). "Overlap connective tissue disease syndromes.". Autoimmune Rev 12 (3): 363–73.
8. Rahman A, Isenberg DA. Systemic lupus erythematosus. New England Journal of Medicine 2008; 358(9): 929–939.
9. Murphy G, Lisnevskaia L, Isenberg D. Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatment. Lancet 2013; 382: 809-818.
10. Ludvigsson JF, Rubio-Tapia A, Chowdhary V, Murray JA, Simard JF. Increased risk of systemic lupus erythematosus in 29,000 patients with biopsy-verified celiac disease. J Rheumatol. 2012; 39(10): 1964-1970.
11. Husby S, Koletzko S, Korponay-Szabó IR, Mearin ML, Phillips A, Shamir R, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac dis-ease. J Pediatr Gastroenterol Nutr. 2012; 54(1): 136-160.
12. Takeno M, Ishigatsubo Y. Intestinal manifestations in systemic lupus erythematosus. Intern Med. 2006; 45: 41–42.
13. Rubio-Tapia A, Kyle RA, Kaplan EL, et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology. 2009; 137(1): 88-93.
14. Luijten RK, Fritsch-Stork RD, Bijlsma JW, Derksen RH. The use of glucocorticoids in systemic lupus erythematosus. After 60 years still more an art than science. Autoimmun Rev 2013; 12: 617-628.

Additional Files

Published

2015-03-31

Issue

Section

INTERNAL MEDICINE - PEDIATRICS